Bicara Therapeutics Inc. · NASDAQ:BCAX
Ra Capital Management, L.P. reported a 11.50% stake in Bicara Therapeutics Inc. (Schedule 13D/A)
Event Feb 26, 2026 · Filed Mar 2, 2026
Ra Capital Management, L.P. reported a 11.50% stake in Bicara Therapeutics Inc., 7,279,739 shares, with active intent on Feb 26, 2026. Filed Mar 2, 2026 (Schedule 13D/A).
- Stake
- 11.50%
- Shares
- 7,279,739
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 11.50% | 7,279,739 |
| Peter Kolchinsky | 11.50% | 7,279,739 |
| Rajeev Shah | 11.50% | 7,279,739 |
| RA Capital Healthcare Fund, L.P. | 7.30% | 4,603,418 |
Source
Related
- Bicara Therapeutics Inc.
- Ra Capital Management, L.P.
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026